Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study
- Resource Type
- Article
- Source
- In
Vaccine 19 February 2014 32(9):1072-1078 - Subject
- Language
- ISSN
- 0264-410X